Shrikhande SV, Sivasanker M. Laparoscopic pancreatoduodenectomy: How far have we come and where are we headed? World J Gastrointest Surg 2015; 7(8): 128-132 [PMID: 26328031 DOI: 10.4240/wjgs.v7.i8.128]
Corresponding Author of This Article
Shailesh V Shrikhande, MS, MD, FRCS (Hon), Chief (Gastrointestinal and Hepato-Pancreato-Biliary Service), Professor (Department of Surgical Oncology), Convener (GI Disease Management Group), Department of Surgical Oncology, Tata Memorial Hospital, Ernest Borges Marg, Parel, Mumbai 400012, India. shailushrikhande@hotmail.com
Research Domain of This Article
Surgery
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Aug 27, 2015; 7(8): 128-132 Published online Aug 27, 2015. doi: 10.4240/wjgs.v7.i8.128
Laparoscopic pancreatoduodenectomy: How far have we come and where are we headed?
Shailesh V Shrikhande, Masillamany Sivasanker
Shailesh V Shrikhande, Masillamany Sivasanker, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai 400012, India
Author contributions: Both authors contributed to this manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Shailesh V Shrikhande, MS, MD, FRCS (Hon), Chief (Gastrointestinal and Hepato-Pancreato-Biliary Service), Professor (Department of Surgical Oncology), Convener (GI Disease Management Group), Department of Surgical Oncology, Tata Memorial Hospital, Ernest Borges Marg, Parel, Mumbai 400012, India. shailushrikhande@hotmail.com
Telephone: +91-22-24144489 Fax: +91-22-24148114
Received: February 4, 2015 Peer-review started: February 5, 2015 First decision: April 10, 2015 Revised: May 25, 2015 Accepted: June 9, 2015 Article in press: June 11, 2015 Published online: August 27, 2015 Processing time: 209 Days and 11.2 Hours
Core Tip
Core tip: This editorial while discussing the evidence and controversies surrounding minimally invasive pancreatoduodenectomy, aims to update the reader about the highest level of evidence accumulated over the past few years. Pancreatoduodenectomy remains a demanding procedure even in the open approach and only few surgeons in high volume centres have published the outcomes following minimally invasive pancreatoduodenectomy. All these reports are retrospective data with inherent problems related to bias. To settle this issue, any randomized trial is unlikely to happen given the complexity of the cancer and patient selection for surgery in a resectable cancer. All these issues have been addressed in this editorial so that the pros and cons of minimally invasive pancreatoduodenectomy have been well conveyed and the reader takes home a balanced message.
